| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3009160 |
| Definition | An antifungal compound that is converted into fluorouracil inside cells, thereby impairing the synthesis of proteins and DNA. This drug should almost always be used in combination with amphotericin B for systemic fungal infections, but the ratio is important since flucytosine can increase the toxicity of amphotericin B and vice versa. Flucytosine is typically indicated for Candida and Cryptococcus infections. |
| SMILES | NC1=C(F)C=NC(=O)N1 |
| PubChem | 3366 |
| ChEMBL | CHEMBL1463 |
| CHEBI | 5100 |
| CAS | 2022-85-7 |
| Drug Class | nucleoside antibiotic |
| Classification | 2 ontology terms | Show |
| Parent Term(s) | 1 ontology terms | Show + nucleoside antibiotic [Drug Class] |
| Sub-Term(s) | 2 ontology terms | Show + Nakaseomyces glabratus Fur1 with mutations associated with resistance to 5-fluorocytosine confers_resistance_to_antibiotic + Cryptococcus neoformans Ura6 uridylate kinase with mutations conferring resistance to 5-fluorocytosine confers_resistance_to_antibiotic |
| Publications | GRUNBERG E, et al. 1963. Antimicrob Agents Chemother (Bethesda) 161:566-8 CHEMOTHERAPEUTIC ACTIVITY OF 5-FLUOROCYTOSINE. (PMID 14274962) |
| Curator | Description | Most Recent Edit |
|---|